Sign In
Buy REGN
$628.73
+9.78 (+1.58%)
At Close: Jun 04, 2026
Regeneron Pharmaceuticals shares rise on FDA approval of higher dose of eye disorder drug EYLEA
09:01am, Monday, 21'st Aug 2023
Regeneron Pharmaceuticals (NASDAQ:REGN) shares moved higher in pre-market trading after the biotechnology company reported on Friday that a higher dose of its eye disorder drug EYLEA has been approved
Regeneron shares climb after FDA approval of macular degeneration treatment
07:52am, Monday, 21'st Aug 2023
Shares of Regeneron Pharmaceuticals Inc. REGN, +1.97% gained 1.4% premarket on Monday after the company said late Friday that the U.S. Food and Drug Administration had approved a higher-dose formulati
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
06:30am, Monday, 21'st Aug 2023
Regeneron Pharmaceuticals has delivered market-beating results for shareholders over the prior 10 years. With competition heating up, however, the biotech may be entering a period of slowing growth.
Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rating Upgrade)
06:18am, Saturday, 19'th Aug 2023
Regeneron reported strong Q2 2023 financial results, with an 11% YoY revenue surge to $3.2B, outperforming expectations. The FDA approved high-dose Eylea (8 mg), offering less frequent treatment, addr
US FDA approves Regeneron's 8-mg dose of eye disease drug Eylea
07:22pm, Friday, 18'th Aug 2023
The U.S. Food and Drug Administration approved the 8-mg dose of Regeneron Pharmaceuticals' eye disease drug Eylea, the company said in a statement on Friday.
Regeneron gets FDA green light on first treatment for life-threatening immune disease
02:11pm, Friday, 18'th Aug 2023
Regeneron Pharmaceuticals Inc. REGN, +0.55% said Friday that the U.S. Food and Drug Administration has approved its treatment for CHAPLE disease, a rare and life-threatening hereditary immune disease.
Regeneron's (REGN) Application for Blood Cancer Drug Accepted
02:05pm, Friday, 18'th Aug 2023
Regeneron's (REGN) application seeking approval of odronextamab for patients with relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma gets accepted for review in the EU.
3 Strong Biotech Performers To Watch As Sector Nears Breakout
07:16am, Thursday, 17'th Aug 2023
The biotech sector, iShares Biotechnology ETF NASDAQ: IBB, has been trading in a tight consolidation for several months. The ETF has a 50-day range of $124.38 and $131.81.
The 7 Best Value Stocks to Buy in August
09:15pm, Thursday, 10'th Aug 2023
While several market ideas have blossomed this year, many are overpriced, which naturally draws eyes to the best value stocks to buy. Here, we're talking about publicly traded securities that trade at
Regeneron (REGN) to Buy Decibel, Gains on Hearing Loss Therapies
01:45pm, Thursday, 10'th Aug 2023
Regeneron (REGN) further builds upon its collaboration with Decibel by acquiring the company to expand its gene therapy programs for hearing loss.
Decibel Therapeutics Shares Soar on Acquisition by Regeneron Pharmaceuticals
12:35pm, Wednesday, 09'th Aug 2023
Shares of Decibel Therapeutics skyrocketed after Regeneron Pharmaceuticals agreed to buy the biotech firm for up to $213 million to expand its gene therapy pipeline.
Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal
10:00am, Wednesday, 09'th Aug 2023
Decibel Therapeutics (NASDAQ: DBTX ) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (NASDAQ: REGN ). This deal has Regeneron Pharmaceuticals agreeing to acqui
Decibel Therapeutics shoots up 72% on Regeneron bid
09:43am, Wednesday, 09'th Aug 2023
Shares of Boston's Decibel Therapeutics Inc soared 72% in the first minutes of trading after Regeneron Pharmaceuticals weighed looks calculated to be a knock-out bid for the tiny drug developer. The
Regeneron buying small cap Decibel Therapeutics for $4 a share
07:55am, Wednesday, 09'th Aug 2023
Regeneron Pharmaceuticals Inc. REGN, +0.72% said Wednesday it would pay $4 a share for Decibel Therapeutics Inc. DBTX, +1.09%, a 43% premium over its closing price of $2.79 a share in the previous ses
2 Top Stocks to Buy in August and Hold Forever
09:00am, Sunday, 06'th Aug 2023
Both of these companies are proven innovators in a necessary industry. Regeneron has two major products and a solid pipeline to drive excellent results.
